The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic alterations and their pathologic responses in high-risk localized prostate cancer (HRLPC) in subprotocol 1 of the Genomic Umbrella Neoadjuvant study (GUNS).
 
Martin Gleave
Stock and Other Ownership Interests - Sustained Therapeutics
Honoraria - AbCellera; Astellas Pharma; AstraZeneca; Bayer; Gandeeva; Janssen; Pfizer
Consulting or Advisory Role - AbCellera; Astellas Pharma; AstraZeneca; Bayer; Gandeeva Therapeutics; Janssen; Pfizer
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - ST-CP; ST-POP
 
Eric Belanger
No Relationships to Disclose
 
Joshua Scurll
No Relationships to Disclose
 
Htoo Zarni Oo
No Relationships to Disclose
 
Lucia Nappi
Honoraria - Bayer; Ipsen; Janssen; Pfizer; Tersera
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Novartis; Pfizer
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - IVERMECTIN ANALOGUE COMPOUND THERAPEUTICS FOR HEAT SHOCK PROTEIN-27 (HSP27) INHIBITION, METHODS AND USES ASSOCIATED THEREWITH provisional number: 62/756,707
Travel, Accommodations, Expenses - Pfizer
 
Himisha Beltran
Consulting or Advisory Role - AstraZeneca; Bayer; Daicchi Sankyo; Merck; Novartis; Pfizer; Sanofi
Research Funding - Bristol Myers Squibb Foundation (Inst); Circle Pharma (Inst); Daiichi Sankyo (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Alexander Wyatt
Honoraria - AstraZeneca; EMD Serono; Genentech; Janssen; Merck; Pfizer
Research Funding - ESSA (Inst); Promontory Therapeutics (Inst); Tyra Biosciences (Inst)
 
Miles Mannas
Stock and Other Ownership Interests - Hexamer Therapeutics
Honoraria - Abbvie; Bayer; Janssen; Tersera
Consulting or Advisory Role - Bayer; Photocure; TerSerra
Research Funding - Tersera
Travel, Accommodations, Expenses - Photocure
 
Peter Black
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Combat Medical; EMD Serono; Ferring; Janssen Oncology; Merck; Nanobot; Nanobot; NanOlogy; Nonagen Bioscience; Pfizer; Photocure; Prokarium; Sumitomo Pharma Oncology; TerSera; Tolmar; Verity Pharmaceuticals
Speakers' Bureau - Bayer; Janssen Oncology; Pfizer; TerSera
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
 
Amina Zoubeidi
No Relationships to Disclose
 
Jonathan Ma
No Relationships to Disclose
 
Doron Berlin
No Relationships to Disclose
 
Tiiu Sildva
No Relationships to Disclose
 
Theo Van Der Kwast
No Relationships to Disclose
 
Neil Fleshner
Employment - Lilly
Leadership - POINT Biopharma; Verity Pharmaceuticals
Stock and Other Ownership Interests - Verity Pharmaceuticals
Honoraria - Amgen; Astellas Medivation; Bayer; Janssen
Consulting or Advisory Role - Hybridyne Health
Research Funding - Amgen; Janssen; Roche